Journal Home
Search for

Volume 196, Issue 2, Pages 772-778 (February 2008)


View previous. 37 of 65 View next.

High prevalence of markers of coronary heart disease among Greenland Inuit

Marit Eika JørgensenacCorresponding Author Informationemail address, Peter Bjerregaarda, Jens Jørgen Kjærgaardb, Knut Borch-Johnsenc

Received 30 August 2006; received in revised form 9 January 2007; accepted 15 January 2007. published online 16 February 2007.

Abstract 

Objective

It is a common notion that coronary heart disease (CHD) is rare among the Inuit, possibly due to a high intake of omega-3-fatty acids. The scientific evidence for this is weak and to some extent based on uncertain mortality statistic. The aim of this study was to assess the prevalence of markers of CHD among Greenland Inuit, and to study associations between markers of CHD and behavioral and biological variables.

Design

We studied prevalence of angina pectoris (AP), self-reported myocardial infarction (MI), and ECG defined MI and ischaemia in a population survey among 1316 Inuit living in Greenland. Blood tests were supplemented by structured interviews, anthropometry, and measurements of blood pressure, and the participants received an oral glucose tolerance test.

Results

The prevalence of symptomatic CHD (AP, self-reported MI) was 7.3% among men and 6.9% among women, and 12.2% and 13.4% of men and women had ischaemic ECG changes. The overall prevalence of CHD (AP+self-reported MI+ECG defined MI) was 10.8% in men and 10.2% in women. The highest prevalence was observed in the least westernized areas in Greenland. Physical inactivity, low education, dyslipidemia, hypertension and diabetes were associated with CHD.

Conclusion

The prevalence of markers of CHD was not different from that in Western populations. The Inuit is a population undergoing rapid social and health transitions, with the emergence of cardiovascular risk factors, and there is a need for critical rethinking of cardiovascular epidemiology in this population.

a Centre for Health Research in Greenland, National Institute of Public Health, Copenhagen, Denmark

b Department of Internal Medicine, Queen Ingrid's Hospital, Nuuk, Greenland

c Steno Diabetes Centre, Gentofte, Denmark

Corresponding Author InformationCorresponding author at: National Institute of Public Health, Øster Farimagsgade 5A, 1399 Copenhagen, Denmark. Tel.: +45 3920 7777.

PII: S0021-9150(07)00049-4

doi:10.1016/j.atherosclerosis.2007.01.008


View previous. 37 of 65 View next.